Investment supports continued Phase 1 clinical advancement of SynKIRTM-110 in advanced solid tumors and SynKIRTM-310 in B cell non-Hodgkin lymphoma Initial clinical data from STAR-101 Phase 1 trial of SynKIRTM-110 to be presented at AACR 2026 Late-Breaking Clinical Trials Plenary Session on...
2026 Copyright © News-Matic.com. All Rights Reserved
